According to the consensus and the recommendations of the European Neuroendocrine Tumor Society (ENETS), the frequency of appendicular neuroendocrine tumors (NETs) is 0.15-0.6/100 000 a year. They are found a little more often in women aged between 40 and 50. Neuroendocrine neoplasms of the appendix are about 30 to 80% of all appendicular tumors. Their evolution is usually asymptomatic. They are diagnosed accidentally during a conventional or laparoscopic appendectomy. In the past, the surgical approach used to depend on the localization of the tumor. Currently, its localization is not a significant factor in the choice of a surgical approach. Our purpose wass to present the consensus guideline and the recommendations of ENETS 2017 for surgical procedures in neuroendocrine neoplasms of the appendix and analyze the difference in the survival rate in different surgical interventions. The literature overview includes studies on surgical treatment of neuroendocrine neoplasms of the appendix and takes into consideration the last consensus guideline of ENETS 2017 on the topic. ENETS recommends a simple appendectomy in well- differentiated appendix tumors smaller than 2 cm, regardless of their localization. Right hemicolectomy is performed for in tumors sized between 1 cm and 2 cm with positive resection lines, with deep mesoappendiceal invasion, high proliferation activity (G2) and vascular invasion. For tumors over larger than 2 cm – right hemicolectomy is recommended. Although current studies have pointed out no significant differences in survival rates between appendectomy for neuroendocrine neoplasms of the appendix and right hemicolectomy, ENETS 2017 suggests that the latest consensus guidelines should be followed.
1. Pape F, Niederle B, Costa F, Gross D, Kelestimur F, Knigge U, et al. ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas). Neuroendocrinology. 2016;103(2):144-52.
2. Hsu C, Rashid A, Xing Y, Chiang Y, Chagpar R, Fournier K, et al. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol. 2013;107:136-43.
3. Carbonero R, Capdevila J, Herrero G, Perez J, Prado M, Orduna V, et al. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol. 2010;21(9):1794-803.
4. Quaedvlieg P, Visser O, Lamers C, Heijen M, Taal B. Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epidemiological study with 2,391 patients. Ann Oncol. 2001;12:1295-300.
5. Boxberger N, Redlich A, Boger Ch, Leuschner I, Schweinitz D, Vorwerk H. Neuroendocrine tumors of the appendix in children and adolescents. Pediatr Blood Cancer. 2013;60:65- 70.
6. Goede A, Caplin M, Winslet M. Carcinoid tumour of the appendix. Br J Surg. 2003;90:1317-22.
7. Volante M, Daniele L, Asioli S, Cassoni P, Comino A, Coverlizza S. Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix. Am J Surg Pathol. 2013;37:606-12.
8. Moertel C, Weiland L, Nagorney D, Dockerty M. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med. 1987;317:1699- 701.
9. Fornaro R, Frascio M, Sticchi C, Salvo L,Stabilini C, Mandolfino F, et al. Appendectomy or right hemicolectomy in the treatment of appendiceal carcinoid tumors? Tumori. 2007;93:587-90.
10. Pape U, Perren A, Niederle B, Gross D, Gress T, Costa F, et al. ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology. 2012;95:135-56.
11. Tang L. Epithelial neoplasms of the appendix. Arch Pathol Lab Med. 2010;134:1612-20.
12. Bamboat Z, Berger D. Is right hemicolectomy for 2.0-cm appendiceal carcinoids justified? Arch Surg. 2006;141:349-52.
13. Dunn J. Carcinoid tumors of the appendix: 21 cases, with a review of the literature. NZ Med J. 1982;95:73-76.